Skip to main content

IQVIA income statement

  • IQV · NYSE
  • Biotechnology
  • Life Sciences Tools & Services
  • S&P 500
$265.12−2.21%Close 13 Nov 2026 · Market value $43.51B

IQVIA reported revenue of $16.3 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 5.9% from fiscal 2024. Net income was $1.36 billion and diluted earnings per share $7.84.

From IQVIA's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

IQVIA income statement, annual
USDFY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$4.33B$4.87B$5.10B$5.46B$5.74B$6.88B$9.74B$10.41B$11.09B$11.36B$13.87B$14.41B$14.98B$15.40B$16.31B$17.31B
Revenue growth—+12.4%+4.8%+7.1%+5.1%+19.9%+41.6%+6.9%+6.5%+2.4%+22.1%+3.9%+4.0%+2.8%+5.9%—
Research and development$9.99M$10.43M$4.96M$5.79M$3.34M———————————
Selling, general and administrative$762.3M$817.8M$860.5M$781.0M$815.0M$1.02B$1.62B$1.72B$1.73B$1.79B$1.96B$2.07B$2.05B$1.99B$2.00B$2.11B
Operating income$345.3M$396.4M$462.3M$590.0M$646.0M$576.0M$665.0M$741.0M$777.0M$731.0M$1.39B$1.80B$1.98B$2.20B$2.18B$2.22B
Operating margin8.0%8.1%9.1%10.8%11.3%8.4%6.8%7.1%7.0%6.4%10.0%12.5%13.2%14.3%13.4%12.8%
Interest expense$109.1M$134.4M$123.5M$101.0M$101.0M$144.0M$346.0M$414.0M$447.0M$416.0M$375.0M$416.0M$672.0M$670.0M$729.0M$785.0M
Income before tax$184.7M$267.4M$323.1M$501.0M$539.0M$416.0M$294.0M$328.0M$352.0M$373.0M$1.13B$1.36B$1.46B$1.67B$1.59B$1.55B
Income tax expense$15.11M$93.36M$95.97M$149.0M$159.0M$325.0M−$992.0M$59.00M$116.0M$72.00M$163.0M$260.0M$101.0M$301.0M$252.0M$254.0M
Effective tax rate8.2%34.9%29.7%29.7%29.5%78.1%−337%18.0%33.0%19.3%14.5%19.1%6.9%18.0%15.8%16.4%
Net income$241.8M$177.5M$226.6M$357.0M$387.0M$72.00M$1.28B$259.0M$191.0M$279.0M$966.0M$1.09B$1.36B$1.37B$1.36B$1.39B
Net margin5.6%3.6%4.4%6.5%6.7%1.0%13.1%2.5%1.7%2.5%7.0%7.6%9.1%8.9%8.3%8.1%
EPS · diluted$2.05$1.51$1.77$2.72$3.08$0.47$5.74$1.24$0.96$1.43$4.95$5.72$7.29$7.49$7.84$8.25
Diluted weighted average shares118M118M128M131M126M152M223M208M200M195M195M191M186M183M174M169M
Basic weighted average shares116M116M124M128M123M149M218M204M195M191M191M188M184M181M172M167M
EBITDA$437.3M$494.7M$569.8M$711.0M$774.0M$865.0M$1.68B$1.88B$1.98B$2.02B$2.66B$2.93B$3.10B$3.32B$3.33B$3.44B
EBITDA margin10.1%10.2%11.2%13.0%13.5%12.6%17.2%18.1%17.8%17.8%19.2%20.3%20.7%21.5%20.4%19.9%
Depreciation & amortization$92.00M$98.29M$107.5M$121.0M$128.0M$289.0M$1.01B$1.14B$1.20B$1.29B$1.26B$1.13B$1.13B$1.11B$1.14B$1.22B
Stock-based compensation$14.13M$25.93M$22.83M$30.00M$38.00M$106.0M$106.0M$113.0M$146.0M$95.00M$170.0M$194.0M$217.0M$206.0M$247.0M$303.0M

Quarterly

IQVIA income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$3.87B$3.74B$3.81B$3.90B$3.96B$3.83B$4.02B$4.10B$4.36B$4.15B$4.37B$4.43B
Gross profit—$827.0M$863.0M$915.0M————————
Gross margin—22.1%22.6%23.5%————————
Selling, general and administrative$556.0M$508.0M$509.0M$522.0M$453.0M$508.0M$509.0M$514.0M$468.0M$502.0M$574.0M$569.0M
Operating income$501.0M$506.0M$520.0M$550.0M$626.0M$496.0M$506.0M$553.0M$627.0M$514.0M$506.0M$572.0M
Operating margin13.0%13.5%13.6%14.1%15.8%13.0%12.6%13.5%14.4%12.4%11.6%12.9%
Interest expense$181.0M$166.0M$163.0M$170.0M$171.0M$165.0M$182.0M$189.0M$193.0M$192.0M$197.0M$203.0M
Income before tax$373.0M$340.0M$436.0M$349.0M$544.0M$323.0M$323.0M$408.0M$537.0M$328.0M$301.0M$386.0M
Income tax expense−$102.0M$49.00M$75.00M$65.00M$112.0M$61.00M$56.00M$76.00M$59.00M$59.00M$60.00M$76.00M
Effective tax rate−27.3%14.4%17.2%18.6%20.6%18.9%17.3%18.6%11.0%18.0%19.9%19.7%
Net income$469.0M$288.0M$363.0M$285.0M$437.0M$249.0M$266.0M$331.0M$514.0M$274.0M$256.0M$350.0M
Net margin12.1%7.7%9.5%7.3%11.0%6.5%6.6%8.1%11.8%6.6%5.9%7.9%
EPS · diluted$2.54$1.56$1.97$1.55$2.42$1.40$1.54$1.93$2.99$1.61$1.53$2.10
Diluted weighted average shares185M184M184M184M181M177M173M172M172M170M167M167M
Basic weighted average shares182M182M182M182M179M176M172M170M170M168M166M165M
EBITDA$817.0M$770.0M$789.0M$828.0M$929.0M$761.0M$782.0M$839.0M$944.0M$802.0M$798.0M$893.0M
EBITDA margin21.1%20.6%20.7%21.3%23.5%19.9%19.5%20.5%21.6%19.3%18.3%20.2%
Depreciation & amortization$316.0M$264.0M$269.0M$278.0M$303.0M$265.0M$276.0M$286.0M$317.0M$288.0M$292.0M$321.0M
Stock-based compensation$45.00M$56.00M$48.00M$54.00M$48.00M$72.00M$60.00M$55.00M$60.00M$65.00M$95.00M$83.00M

The main figures as JSON and plain text. See data and methodology.

IQV in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.